Search

Your search keyword '"Tiedt, Ralph"' showing total 31 results
Start Over Author "Tiedt, Ralph" Publisher american association for cancer research (aacr)
31 results on '"Tiedt, Ralph"'

1. Abstract 3449: Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction

Author

Gavory, Gerald, primary, Ghandi, Mahmoud, additional, d’Alessandro, Anne-Cecile, additional, Bonenfant, Debora, additional, Cabanski, Maciej, additional, Cantagallo, Lisa, additional, Chicas, Agustin, additional, Chen, Qian, additional, Diesslin, Anna, additional, King, Christopher, additional, Massafra, Vittoria, additional, Narayan, Rajiv, additional, Osmont, Arnaud, additional, Peck, Dave, additional, Ortiz, Carolina Perdomo, additional, Schillo, Martin, additional, Singh, Ambika, additional, Tiedt, Ralph, additional, Tortoioli, Simone, additional, Buonamici, Silvia, additional, Janku, Filip, additional, Wallace, Owen, additional, and Fasching, Bernhard, additional

Published
2023
Full Text
View/download PDF

2. Supplementary Methods from Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., primary, Sanghavi, Sneha, primary, Jeffery, Douglas, primary, Liu, Lijuan, primary, Sheppard, Kelly Ann, primary, Wagner, Sabrina, primary, Stamm, Christelle, primary, Buness, Andreas, primary, Chatenay-Rivauday, Christian, primary, Yao, Yao, primary, He, Feng, primary, Lu, Chris X., primary, Guagnano, Vito, primary, Metz, Thomas, primary, Finan, Peter M., primary, Hofmann, Francesco, primary, Sellers, William R., primary, Porter, Jeffrey A., primary, Myer, Vic E., primary, Graus-Porta, Diana, primary, Wilson, Christopher J., primary, Buckler, Alan, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figures 1-5 from Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., primary, Sanghavi, Sneha, primary, Jeffery, Douglas, primary, Liu, Lijuan, primary, Sheppard, Kelly Ann, primary, Wagner, Sabrina, primary, Stamm, Christelle, primary, Buness, Andreas, primary, Chatenay-Rivauday, Christian, primary, Yao, Yao, primary, He, Feng, primary, Lu, Chris X., primary, Guagnano, Vito, primary, Metz, Thomas, primary, Finan, Peter M., primary, Hofmann, Francesco, primary, Sellers, William R., primary, Porter, Jeffrey A., primary, Myer, Vic E., primary, Graus-Porta, Diana, primary, Wilson, Christopher J., primary, Buckler, Alan, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table 1 from Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., primary, Liu, Leah Y., primary, Siravegna, Giulia, primary, Leshchiner, Ignaty, primary, Ahronian, Leanne G., primary, Lennerz, Jochen K., primary, Vu, Phuong, primary, Deshpande, Vikram, primary, Kambadakone, Avinash, primary, Mussolin, Benedetta, primary, Reyes, Stephanie, primary, Henderson, Laura, primary, Sun, Jiaoyuan Elisabeth, primary, Van Seventer, Emily E., primary, Gurski, Joseph M., primary, Baltschukat, Sabrina, primary, Schacher-Engstler, Barbara, primary, Barys, Louise, primary, Stamm, Christelle, primary, Furet, Pascal, primary, Ryan, David P., primary, Stone, James R., primary, Iafrate, A. John, primary, Getz, Gad, primary, Porta, Diana Graus, primary, Tiedt, Ralph, primary, Bardelli, Alberto, primary, Juric, Dejan, primary, Corcoran, Ryan B., primary, Bardeesy, Nabeel, primary, and Zhu, Andrew X., primary

Published
2023
Full Text
View/download PDF

5. Data from Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., primary, Sanghavi, Sneha, primary, Jeffery, Douglas, primary, Liu, Lijuan, primary, Sheppard, Kelly Ann, primary, Wagner, Sabrina, primary, Stamm, Christelle, primary, Buness, Andreas, primary, Chatenay-Rivauday, Christian, primary, Yao, Yao, primary, He, Feng, primary, Lu, Chris X., primary, Guagnano, Vito, primary, Metz, Thomas, primary, Finan, Peter M., primary, Hofmann, Francesco, primary, Sellers, William R., primary, Porter, Jeffrey A., primary, Myer, Vic E., primary, Graus-Porta, Diana, primary, Wilson, Christopher J., primary, Buckler, Alan, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

6. Data from Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., primary, Liu, Leah Y., primary, Siravegna, Giulia, primary, Leshchiner, Ignaty, primary, Ahronian, Leanne G., primary, Lennerz, Jochen K., primary, Vu, Phuong, primary, Deshpande, Vikram, primary, Kambadakone, Avinash, primary, Mussolin, Benedetta, primary, Reyes, Stephanie, primary, Henderson, Laura, primary, Sun, Jiaoyuan Elisabeth, primary, Van Seventer, Emily E., primary, Gurski, Joseph M., primary, Baltschukat, Sabrina, primary, Schacher-Engstler, Barbara, primary, Barys, Louise, primary, Stamm, Christelle, primary, Furet, Pascal, primary, Ryan, David P., primary, Stone, James R., primary, Iafrate, A. John, primary, Getz, Gad, primary, Porta, Diana Graus, primary, Tiedt, Ralph, primary, Bardelli, Alberto, primary, Juric, Dejan, primary, Corcoran, Ryan B., primary, Bardeesy, Nabeel, primary, and Zhu, Andrew X., primary

Published
2023
Full Text
View/download PDF

7. Data from Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., primary, Sanghavi, Sneha, primary, Jeffery, Douglas, primary, Liu, Lijuan, primary, Sheppard, Kelly Ann, primary, Wagner, Sabrina, primary, Stamm, Christelle, primary, Buness, Andreas, primary, Chatenay-Rivauday, Christian, primary, Yao, Yao, primary, He, Feng, primary, Lu, Chris X., primary, Guagnano, Vito, primary, Metz, Thomas, primary, Finan, Peter M., primary, Hofmann, Francesco, primary, Sellers, William R., primary, Porter, Jeffrey A., primary, Myer, Vic E., primary, Graus-Porta, Diana, primary, Wilson, Christopher J., primary, Buckler, Alan, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figures 1 - 6 from Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., primary, Liu, Leah Y., primary, Siravegna, Giulia, primary, Leshchiner, Ignaty, primary, Ahronian, Leanne G., primary, Lennerz, Jochen K., primary, Vu, Phuong, primary, Deshpande, Vikram, primary, Kambadakone, Avinash, primary, Mussolin, Benedetta, primary, Reyes, Stephanie, primary, Henderson, Laura, primary, Sun, Jiaoyuan Elisabeth, primary, Van Seventer, Emily E., primary, Gurski, Joseph M., primary, Baltschukat, Sabrina, primary, Schacher-Engstler, Barbara, primary, Barys, Louise, primary, Stamm, Christelle, primary, Furet, Pascal, primary, Ryan, David P., primary, Stone, James R., primary, Iafrate, A. John, primary, Getz, Gad, primary, Porta, Diana Graus, primary, Tiedt, Ralph, primary, Bardelli, Alberto, primary, Juric, Dejan, primary, Corcoran, Ryan B., primary, Bardeesy, Nabeel, primary, and Zhu, Andrew X., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Tables 1-3 and Table 5 from Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., primary, Sanghavi, Sneha, primary, Jeffery, Douglas, primary, Liu, Lijuan, primary, Sheppard, Kelly Ann, primary, Wagner, Sabrina, primary, Stamm, Christelle, primary, Buness, Andreas, primary, Chatenay-Rivauday, Christian, primary, Yao, Yao, primary, He, Feng, primary, Lu, Chris X., primary, Guagnano, Vito, primary, Metz, Thomas, primary, Finan, Peter M., primary, Hofmann, Francesco, primary, Sellers, William R., primary, Porter, Jeffrey A., primary, Myer, Vic E., primary, Graus-Porta, Diana, primary, Wilson, Christopher J., primary, Buckler, Alan, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 4 from Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., primary, Sanghavi, Sneha, primary, Jeffery, Douglas, primary, Liu, Lijuan, primary, Sheppard, Kelly Ann, primary, Wagner, Sabrina, primary, Stamm, Christelle, primary, Buness, Andreas, primary, Chatenay-Rivauday, Christian, primary, Yao, Yao, primary, He, Feng, primary, Lu, Chris X., primary, Guagnano, Vito, primary, Metz, Thomas, primary, Finan, Peter M., primary, Hofmann, Francesco, primary, Sellers, William R., primary, Porter, Jeffrey A., primary, Myer, Vic E., primary, Graus-Porta, Diana, primary, Wilson, Christopher J., primary, Buckler, Alan, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

11. Data from Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., primary, Liu, Leah Y., primary, Siravegna, Giulia, primary, Leshchiner, Ignaty, primary, Ahronian, Leanne G., primary, Lennerz, Jochen K., primary, Vu, Phuong, primary, Deshpande, Vikram, primary, Kambadakone, Avinash, primary, Mussolin, Benedetta, primary, Reyes, Stephanie, primary, Henderson, Laura, primary, Sun, Jiaoyuan Elisabeth, primary, Van Seventer, Emily E., primary, Gurski, Joseph M., primary, Baltschukat, Sabrina, primary, Schacher-Engstler, Barbara, primary, Barys, Louise, primary, Stamm, Christelle, primary, Furet, Pascal, primary, Ryan, David P., primary, Stone, James R., primary, Iafrate, A. John, primary, Getz, Gad, primary, Porta, Diana Graus, primary, Tiedt, Ralph, primary, Bardelli, Alberto, primary, Juric, Dejan, primary, Corcoran, Ryan B., primary, Bardeesy, Nabeel, primary, and Zhu, Andrew X., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figures 1 - 6 from Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., primary, Liu, Leah Y., primary, Siravegna, Giulia, primary, Leshchiner, Ignaty, primary, Ahronian, Leanne G., primary, Lennerz, Jochen K., primary, Vu, Phuong, primary, Deshpande, Vikram, primary, Kambadakone, Avinash, primary, Mussolin, Benedetta, primary, Reyes, Stephanie, primary, Henderson, Laura, primary, Sun, Jiaoyuan Elisabeth, primary, Van Seventer, Emily E., primary, Gurski, Joseph M., primary, Baltschukat, Sabrina, primary, Schacher-Engstler, Barbara, primary, Barys, Louise, primary, Stamm, Christelle, primary, Furet, Pascal, primary, Ryan, David P., primary, Stone, James R., primary, Iafrate, A. John, primary, Getz, Gad, primary, Porta, Diana Graus, primary, Tiedt, Ralph, primary, Bardelli, Alberto, primary, Juric, Dejan, primary, Corcoran, Ryan B., primary, Bardeesy, Nabeel, primary, and Zhu, Andrew X., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 1 from Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., primary, Liu, Leah Y., primary, Siravegna, Giulia, primary, Leshchiner, Ignaty, primary, Ahronian, Leanne G., primary, Lennerz, Jochen K., primary, Vu, Phuong, primary, Deshpande, Vikram, primary, Kambadakone, Avinash, primary, Mussolin, Benedetta, primary, Reyes, Stephanie, primary, Henderson, Laura, primary, Sun, Jiaoyuan Elisabeth, primary, Van Seventer, Emily E., primary, Gurski, Joseph M., primary, Baltschukat, Sabrina, primary, Schacher-Engstler, Barbara, primary, Barys, Louise, primary, Stamm, Christelle, primary, Furet, Pascal, primary, Ryan, David P., primary, Stone, James R., primary, Iafrate, A. John, primary, Getz, Gad, primary, Porta, Diana Graus, primary, Tiedt, Ralph, primary, Bardelli, Alberto, primary, Juric, Dejan, primary, Corcoran, Ryan B., primary, Bardeesy, Nabeel, primary, and Zhu, Andrew X., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Tables from Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Author

Baltschukat, Sabrina, primary, Engstler, Barbara Schacher, primary, Huang, Alan, primary, Hao, Huai-Xiang, primary, Tam, Angela, primary, Wang, Hui Qin, primary, Liang, Jinsheng, primary, DiMare, Matthew T., primary, Bhang, Hyo-Eun Carrie, primary, Wang, Youzhen, primary, Furet, Pascal, primary, Sellers, William R., primary, Hofmann, Francesco, primary, Schoepfer, Joseph, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Data from Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer

Author

Tolaney, Sara M., primary, Im, Young-Hyuck, primary, Calvo, Emiliano, primary, Lu, Yen-Shen, primary, Hamilton, Erika, primary, Forero-Torres, Andres, primary, Bachelot, Thomas, primary, Maur, Michela, primary, Fasolo, Angelica, primary, Tiedt, Ralph, primary, Nardi, Lisa, primary, Stammberger, Uz, primary, Abdelhady, Ahmed M., primary, Ruan, Shiling, primary, and Lee, Soo Chin, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Data from Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Author

Baltschukat, Sabrina, primary, Engstler, Barbara Schacher, primary, Huang, Alan, primary, Hao, Huai-Xiang, primary, Tam, Angela, primary, Wang, Hui Qin, primary, Liang, Jinsheng, primary, DiMare, Matthew T., primary, Bhang, Hyo-Eun Carrie, primary, Wang, Youzhen, primary, Furet, Pascal, primary, Sellers, William R., primary, Hofmann, Francesco, primary, Schoepfer, Joseph, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Data from Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Author

Baltschukat, Sabrina, primary, Engstler, Barbara Schacher, primary, Huang, Alan, primary, Hao, Huai-Xiang, primary, Tam, Angela, primary, Wang, Hui Qin, primary, Liang, Jinsheng, primary, DiMare, Matthew T., primary, Bhang, Hyo-Eun Carrie, primary, Wang, Youzhen, primary, Furet, Pascal, primary, Sellers, William R., primary, Hofmann, Francesco, primary, Schoepfer, Joseph, primary, and Tiedt, Ralph, primary

Published
2023
Full Text
View/download PDF

18. Data from A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Author

Tiedt, Ralph, primary, Degenkolbe, Elisa, primary, Furet, Pascal, primary, Appleton, Brent A., primary, Wagner, Sabrina, primary, Schoepfer, Joseph, primary, Buck, Emily, primary, Ruddy, David A., primary, Monahan, John E., primary, Jones, Michael D., primary, Blank, Jutta, primary, Haasen, Dorothea, primary, Drueckes, Peter, primary, Wartmann, Markus, primary, McCarthy, Clive, primary, Sellers, William R., primary, and Hofmann, Francesco, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figures 1-2, Tables 1-4, Methods from A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Author

Tiedt, Ralph, primary, Degenkolbe, Elisa, primary, Furet, Pascal, primary, Appleton, Brent A., primary, Wagner, Sabrina, primary, Schoepfer, Joseph, primary, Buck, Emily, primary, Ruddy, David A., primary, Monahan, John E., primary, Jones, Michael D., primary, Blank, Jutta, primary, Haasen, Dorothea, primary, Drueckes, Peter, primary, Wartmann, Markus, primary, McCarthy, Clive, primary, Sellers, William R., primary, and Hofmann, Francesco, primary

Published
2023
Full Text
View/download PDF

20. Data from A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Author

Tiedt, Ralph, primary, Degenkolbe, Elisa, primary, Furet, Pascal, primary, Appleton, Brent A., primary, Wagner, Sabrina, primary, Schoepfer, Joseph, primary, Buck, Emily, primary, Ruddy, David A., primary, Monahan, John E., primary, Jones, Michael D., primary, Blank, Jutta, primary, Haasen, Dorothea, primary, Drueckes, Peter, primary, Wartmann, Markus, primary, McCarthy, Clive, primary, Sellers, William R., primary, and Hofmann, Francesco, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figures 1-2, Tables 1-4, Methods from A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Author

Tiedt, Ralph, primary, Degenkolbe, Elisa, primary, Furet, Pascal, primary, Appleton, Brent A., primary, Wagner, Sabrina, primary, Schoepfer, Joseph, primary, Buck, Emily, primary, Ruddy, David A., primary, Monahan, John E., primary, Jones, Michael D., primary, Blank, Jutta, primary, Haasen, Dorothea, primary, Drueckes, Peter, primary, Wartmann, Markus, primary, McCarthy, Clive, primary, Sellers, William R., primary, and Hofmann, Francesco, primary

Published
2023
Full Text
View/download PDF

22. Abstract P5-13-18: Upregulation of immune response biomarkers by ribociclib plus endocrine therapy (ET) in paired tumor samples from phase I studies

Author

Juric, Dejan, primary, Ma, Chong, additional, Tiedt, Ralph, additional, Yap, Yoon-Sim, additional, Chiu, Joanne, additional, Munster, Pamela, additional, Ismail-Khan, Roohi, additional, Garcia-Estevez, Laura, additional, Mayer, Ingrid A., additional, Becerra, Carlos, additional, Solovieff, Nadia, additional, Lteif, Agnes, additional, Su, Faye, additional, and Lu, Yen-Shen, additional

Published
2022
Full Text
View/download PDF

23. Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer

Author

Tolaney, Sara M., primary, Im, Young-Hyuck, additional, Calvo, Emiliano, additional, Lu, Yen-Shen, additional, Hamilton, Erika, additional, Forero-Torres, Andres, additional, Bachelot, Thomas, additional, Maur, Michela, additional, Fasolo, Angelica, additional, Tiedt, Ralph, additional, Nardi, Lisa, additional, Stammberger, Uz, additional, Abdelhady, Ahmed M., additional, Ruan, Shiling, additional, and Lee, Soo Chin, additional

Published
2021
Full Text
View/download PDF

24. Abstract 1770: A new DOT1L inhibitor with in vivo activity in mouse models of MLL-translocated leukemia

Author

Weiss, Andreas, primary, Stauffer, Frederic, additional, Clemens, Clemens, additional, Möbitz, Henrik, additional, Ragot, Christian, additional, Beyer, Kim S., additional, Calkins, Keith, additional, Thoma, Claudio, additional, Guthy, Daniel, additional, Kiffe, Michael, additional, Van Eerdenbrugh, Bernard, additional, Sellers, William R., additional, Hofmann, Francesco, additional, Tiedt, Ralph, additional, and Gaul, Christoph, additional

Published
2020
Full Text
View/download PDF

25. Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Author

Baltschukat, Sabrina, primary, Engstler, Barbara Schacher, additional, Huang, Alan, additional, Hao, Huai-Xiang, additional, Tam, Angela, additional, Wang, Hui Qin, additional, Liang, Jinsheng, additional, DiMare, Matthew T., additional, Bhang, Hyo-Eun Carrie, additional, Wang, Youzhen, additional, Furet, Pascal, additional, Sellers, William R., additional, Hofmann, Francesco, additional, Schoepfer, Joseph, additional, and Tiedt, Ralph, additional

Published
2019
Full Text
View/download PDF

26. Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Goyal, Lipika, primary, Saha, Supriya K., additional, Liu, Leah Y., additional, Siravegna, Giulia, additional, Leshchiner, Ignaty, additional, Ahronian, Leanne G., additional, Lennerz, Jochen K., additional, Vu, Phuong, additional, Deshpande, Vikram, additional, Kambadakone, Avinash, additional, Mussolin, Benedetta, additional, Reyes, Stephanie, additional, Henderson, Laura, additional, Sun, Jiaoyuan Elisabeth, additional, Van Seventer, Emily E., additional, Gurski, Joseph M., additional, Baltschukat, Sabrina, additional, Schacher-Engstler, Barbara, additional, Barys, Louise, additional, Stamm, Christelle, additional, Furet, Pascal, additional, Ryan, David P., additional, Stone, James R., additional, Iafrate, A. John, additional, Getz, Gad, additional, Porta, Diana Graus, additional, Tiedt, Ralph, additional, Bardelli, Alberto, additional, Juric, Dejan, additional, Corcoran, Ryan B., additional, Bardeesy, Nabeel, additional, and Zhu, Andrew X., additional

Published
2017
Full Text
View/download PDF

28. Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Author

Harbinski, Fred, primary, Craig, Vanessa J., additional, Sanghavi, Sneha, additional, Jeffery, Douglas, additional, Liu, Lijuan, additional, Sheppard, Kelly Ann, additional, Wagner, Sabrina, additional, Stamm, Christelle, additional, Buness, Andreas, additional, Chatenay-Rivauday, Christian, additional, Yao, Yao, additional, He, Feng, additional, Lu, Chris X., additional, Guagnano, Vito, additional, Metz, Thomas, additional, Finan, Peter M., additional, Hofmann, Francesco, additional, Sellers, William R., additional, Porter, Jeffrey A., additional, Myer, Vic E., additional, Graus-Porta, Diana, additional, Wilson, Christopher J., additional, Buckler, Alan, additional, and Tiedt, Ralph, additional

Published
2012
Full Text
View/download PDF

30. Abstract B232: Activity of a potent and selective phase I ALK inhibitor LDK378 in naive and crizotinib-resistant preclinical tumor models.

Author

Li, Nanxin, primary, Michellys, Pierre-Yves, additional, Kim, Sungjoon, additional, Pferdekamper, AnneMarie Culazzo, additional, Li, Jie, additional, Kasibhatla, Shailaja, additional, Tompkins, Celin S., additional, Steffy, Auzon, additional, Li, Allen, additional, Sun, Frank, additional, Sun, Xiuying, additional, Hua, Su, additional, Tiedt, Ralph, additional, Sarkisova, Yelena, additional, Marsilje, Thomas H., additional, McNamara, Peter, additional, and Harris, Jennifer, additional

Published
2011
Full Text
View/download PDF

31. A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Author

Tiedt, Ralph, primary, Degenkolbe, Elisa, additional, Furet, Pascal, additional, Appleton, Brent A., additional, Wagner, Sabrina, additional, Schoepfer, Joseph, additional, Buck, Emily, additional, Ruddy, David A., additional, Monahan, John E., additional, Jones, Michael D., additional, Blank, Jutta, additional, Haasen, Dorothea, additional, Drueckes, Peter, additional, Wartmann, Markus, additional, McCarthy, Clive, additional, Sellers, William R., additional, and Hofmann, Francesco, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results